Welcome to our website for the KICKSTART study, a clinical research study for people with stage IIIb or IV non-small cell lung cancer (NSCLC).

The KICKSTART study is evaluating an investigational immunotherapy for NSCLC to be added on to an approved immunotherapy.

To learn more details about this research study, please download the brochure that may apply to you or your loved one:

To learn about participating in the KICKSTART study or to see if there is a research study location near you, please scroll down or click on the page links.

Because cancer and all medical conditions can change over time, you may be interested in knowing about this research study and bookmarking this website, even if you do not currently satisfy applicable requirements.

To see if you or a loved one may be able to participate, please complete our pre-qualifying questionnaire.

Has a doctor or other health care provider told you that you have metastatic non-small cell lung cancer (NSCLC)?
 
Yes
No
Unsure
How did you hear about this research study?
 
Please enter your home or work zip code. This zip code will be used to locate a study center near you. Please provide the zip code that would be most convenient to you.
 
Enter 5-digit zip code
Are you 18 years of age or older?
 
Yes
No




By clicking you authorize us to proceed with the pre-screening process and to begin recording your answers. By clicking you also consent to the terms of the Privacy and Confidentiality Policy. Your name and contact information will not be associated with your answers unless you provide this information after you complete the pre-qualifying questionnaire.

Who should complete the pre-qualifying questionnaire?

Any adult who has been diagnosed with stage IIIb or stage IV non-small cell lung cancer.

What if I am helping a person fill out the pre-qualifying questionnaire?

These questions are directed to the person who will participate in the research study if they qualify, so "you" as used in the pre-qualifying questionnaire refers to that person.

Is there an obligation to continue if I complete the pre-qualifying questionnaire?

No. You may take the pre-qualifying questionnaire just to see if you might pre-qualify. Participation in a research study is completely voluntary at every step in the process.

Why is the KICKSTART Study Important?

According to the American Lung Association, non-small cell lung cancer (NSCLC) makes up over 85% of all lung cancer cases. Although progress has been made, lung cancer is still the leading cause of cancer deaths, causing more deaths than breast, prostate, and colon cancers combined.

Lung cancer research is necessary to develop new medications to help provide better treatment options. Before new medications can be approved for public use, they must be tested in research studies like this one.


Click here to learn more about this study.


Participating Cities

Please check back regularly to see if a site is added in your area.

  • Alabama
    •  Daphne
  • Arizona
    •  Glendale
    •  Tucson
  • California
    •  Los Angeles
    •  Merced
    •  Newport Beach
  • Colorado
    •  Colorado Springs
    •  Denver
    •  Pueblo
  • Florida
    •  Brooksville
    •  Hollywood
    •  Palm Bay
    •  Pensacola
  • Georgia
    •  Columbus
  • Kentucky
    •  Lexington
    •  Louisville
  • Maryland
    •  Annapolis
    •  Columbia
  • New York
    •  Binghamton
    •  New York
  • North Carolina
    •  Asheville
  • Ohio
    •  Dover
    •  Kettering
    •  Massillon
    •  Toledo
  • Oregon
    •  Eugene
  • South Dakota
    •  Watertown
  • Texas
    •  Abilene
    •  Austin
    •  Beaumont
    •  Bedford
    •  Dallas
    •  Denton
    •  El Paso
    •  Flower Mound
    •  Ft. Worth
    •  Houston
    •  Midland
    •  Paris
    •  Plano
    •  Tyler
    •  Webster
  • Virginia
    •  Fairfax
  • Washington
    •  Everett
    •  Spokane
  • West Virginia
    •  Morgantown


What is Clinical Research?

Although there are many definitions, a clinical research study is generally considered to be health-related clinical research in people with a specific condition using a pre-defined written protocol.

Click here to learn more about clinical research.

The KICKSTART study is evaluating an investigational immunotherapy for NSCLC to be added on to an approved immunotherapy.


Navigation Powered by The Patient Recruiting Agency ™
© TPRA, 2021
Privacy and Confidentiality Policy

A copy of the Data Protection and Privacy Policy for this website is available at this location: Data Protection and Privacy Policy http://tprausa.com/privacy/